Genetic Analysis AS is a biotechnology company that specializes in diagnostics within the microbiome market. The company has developed the GA-map® technology, which is designed for characterizing the human microbiome. They offer a CE-marked diagnostic test for dysbiosis, specifically aimed at patients with irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD).
In addition to diagnostic services, Genetic Analysis AS engages in clinical research to map the gut microbiota. The company also collaborates on the development of diagnostic solutions for pharmaceutical products. Genetic Analysis AS actively participates in international congresses, such as Biomarkers & Precision Medicine, and has a strong focus on innovation and research within microbiome diagnostics.
